课题基金 / 基金详情

GASTROSCHISIS: A PROSPECTIVE COHORT OUTCOME STUDY

GASTROSCHISIS: A PROSPECTIVE COHORT OUTCOME STUDY
胃裂:一项前瞻性队列结果研究
批准号:
7375013
负责人:
MARY L BRANDT
金额:
$0.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

MARY L BRANDT的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。腹裂发生率约为1/5000活产。该缺陷的特征是位于脐带右侧的边缘光滑的开口,可能是由子宫内右脐静脉的异常复旧引起的。最常见的是胃、小肠和结肠通过缺损疝出。腹裂如果不及时治疗,是与生命不相容的。所有腹裂的婴儿都需要复位疝出的肠和闭合腹壁缺损。腹裂婴儿的传统治疗包括在产房用无菌纱布包裹取出的肠,将婴儿转移到新生儿重症监护室,并进行紧急手术。使用这种方法,肠被减少到腹部和腹壁缺损关闭在手术室。腹裂婴儿的腹腔有时太小,不能容纳疝出的内脏,因为在胎儿发育过程中,肠道已经失去了它的“领地权”。疝出内脏的完全返回和腹壁的一期缝合可导致腹内压过高和肺运动减少。当不可能完全减少取出的内容物时,这发生在20-25%的时间内,硅橡胶“筒仓”用于覆盖取出的肠。随着重力,时间和温和的压力,取出的肠被送回腹部,这个过程通常需要3-10天。一旦获得复位,在第二次手术中移除筒仓并闭合腹部缺损。无论肠道如何缩小,腹裂婴儿都有许多不良结局的风险,包括坏死性小肠结肠炎(NEC)、肠缺血、长时间肠梗阻、败血症、肝损伤、长时间插管和死亡。本研究的目的是前瞻性地回顾所有在德克萨斯儿童医院或Ben Taub综合医院接受腹裂治疗的儿童的预后。将评估的具体结果将包括住院总时间、耐受喂养的时间、额外手术的需要以及并发症的发生,如坏死性小肠结肠炎或中心静脉感染。次要目的是收集低血清白蛋白水平和/或高CRP(C反应蛋白)水平与不良结局之间是否存在相关性的初步数据。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Gastroschisis occurs in approximately 1 in 5000 live births. The defect is is characterized by a smooth-edged opening located to the right of the umbilical cord, probably caused by abnormal involution of the right umbilical vein in utero. Most commonly the stomach, small intestine and colon are herniated through the defect. Gastroschisis is incompatible with life if left untreated. All infants with gastroschisis require reduction of the herniated intestine and closure of the adominal wall defect. Traditional treatment of the infant with gastroschisis consists of wrapping the eviscerated bowel in sterile gauze in the delivery room, transferring the baby to a neonatal intensive care unit, and performing emergent surgery. Using this approach, the bowel is reduced into the abdomen and the abdominal wall defect closed in the operating room. The abdominal cavity in infants with gastroschisis is occasionally too small to accommodate the return of herniated viscera because the bowel has lost its "right of domain" during fetal development. Complete return of herniated viscera and primary closure of the abdominal wall can lead to excessive intra-abdominal pressure and decreased pulmonary excursion. When complete reduction of the eviscerated contents is not possible, which occurs 20-25% of the time, a silastic "silo" is used to cover the eviscerated bowel. With gravity, time, and gentle pressure, the eviscerated bowel is returned to the abdomen, a process that usually takes 3-10 days. Once reduction is obtained, the silo is removed and the abdominal defect is closed in a second operation. Regardless of how the bowel is reduced, infants with gastroschisis are at risk for a number of poor outcomes including necrotizing enterocolitis (NEC), bowel ischemia, prolonged ileus, sepsis, liver injury, prolonged intubation, and death. pardThe purpose of this study is to prospectively review the outcome of all children with gastroschisis at Texas Children's Hospital or Ben Taub General Hospital. Specific outcomes that will be evaluated will include total time in the hospital, time until feedings are tolerated, need for additional surgery , and development of complications such as necrotizing enterocolitis or central line infections. A secondary purpose will be to collect pilot data on whether there is a correlation between low serum albumin levels and/or high CRP (C-reactive protein) levels and poor outcome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GASTROSCHISIS: A PROSPECTIVE COHORT OUTCOME STUDY
  • 批准号:
    8356665
  • 项目类别:
  • 资助金额:
    $0.23万
  • 财政年份:
    2010
  • 负责人:
    MARY L BRANDT
  • 依托单位:
NEONATAL SURGICAL DATABASE: NECROTIZING ENTEROCOLITIS (NEC) PROTOCOL
  • 批准号:
    8356658
  • 项目类别:
  • 资助金额:
    $0.53万
  • 财政年份:
    2010
  • 负责人:
    MARY L BRANDT
  • 依托单位:
ADOLESCENT BARIATRICS ASSESSING HEALTH BENEFITS AND RISKS
  • 批准号:
    8356702
  • 项目类别:
  • 资助金额:
    $2.1万
  • 财政年份:
    2010
  • 负责人:
    MARY L BRANDT
  • 依托单位:
ADOLESCENT BARIATRICS ASSESSING HEALTH BENEFITS AND RISKS (TEEN-LABS U01 DK07249
  • 批准号:
    8166721
  • 项目类别:
  • 资助金额:
    $1.37万
  • 财政年份:
    2009
  • 负责人:
    MARY L BRANDT
  • 依托单位:
海外基金